Heron Therapeutics, Inc. (HRTX) shareholders
Close on Nov 17, 2026Market cap $53.58MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rubric Capital Management LP Joint filing with David Rosen (15.90%) | 30,046,828 | 15.90% | 13D (active) amendment | Oct 15, 2025 |
| David Rosen Joint filing with Rubric Capital Management LP (17.50%) | 29,100,728 | 17.50% | 13D (active) amendment | Aug 8, 2025 |
| Clearline Capital LP Joint filing with Clearline Capital LLC (6.70%), Marc Majzner (6.70%) | 12,235,239 | 6.70% | 13G (passive) amendment | Dec 31, 2025 |
| BlackRock, Inc. | 8,534,567 | 5.60% | 13G (passive) | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of HRTX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 30,046,828 | 15.83% | $12.82M | – | 0.12% |
| Clearline Capital LP | 11,383,961 | 6.00% | $4.86M | −851,278 | 0.29% |
| BlackRock, Inc. | 10,550,750 | 5.56% | $4.50M | +444,328 | 0.00% |
| Velan Capital Investment Management LP | 8,753,290 | 4.61% | $3.74M | – | 2.28% |
| Vanguard Capital Management LLC | 7,782,741 | 4.10% | $3.32M | −27,588 | 0.00% |
| Tejara Capital Ltd | 6,510,795 | 3.43% | $2.78M | +174,040 | 1.14% |
| Tang Capital Management LLC | 6,250,000 | 3.29% | $2.67M | – | 0.12% |
| Geode Capital Management, LLC | 4,270,980 | 2.25% | $1.82M | +260,893 | 0.00% |
| Millennium Management LLC | 4,070,101 | 2.14% | $1.74M | −3,560,426 | 0.00% |
| JW Asset Management, LLC | 3,751,073 | 1.98% | $1.60M | – | 0.50% |
| State Street Corp | 3,228,557 | 1.70% | $1.38M | −615,115 | 0.00% |
| UBS Group AG | 2,997,073 | 1.58% | $1.28M | +711,190 | 0.00% |
| Pale Fire Capital SE | 2,511,478 | 1.32% | $1.07M | −204,850 | 0.08% |
| Marshall Wace, Llp | 2,354,193 | 1.24% | $1.01M | New | 0.00% |
| Congress Park Capital LLC | 2,016,447 | 1.06% | $860.62K | −2,016,290 | 0.23% |
| Richmond Brothers, Inc. | 1,792,319 | 0.94% | $764.96K | +355,614 | 0.40% |
| Vanguard Portfolio Management LLC | 1,580,510 | 0.83% | $674.88K | +271,198 | 0.00% |
| Aqr Capital Management LLC | 1,553,857 | 0.82% | $663.19K | +912,270 | 0.00% |
| Renaissance Technologies LLC | 1,506,900 | 0.79% | $643.15K | −211,400 | 0.00% |
| Vanguard Fiduciary Trust Co | 1,365,119 | 0.72% | $582.91K | +212,405 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 162 | 134M | 70.4% | 21 / 58 | 40 / 22 | 12M | 35M |
| Q1 2026 | 167 | 157M | 82.6% | 31 / 52 | 44 / 29 | 29M | 19M |
| Q4 2025 | 170 | 157M | 82.4% | 25 / 57 | 43 / 25 | 24M | 21M |
| Q3 2025 | 172 | 154M | 81.1% | 19 / 57 | 52 / 16 | 36M | 13M |
| Q2 2025 | 171 | 131M | 69.3% | 24 / 65 | 32 / 17 | 16M | 9M |
| Q1 2025 | 165 | 125M | 65.7% | 25 / 51 | 46 / 18 | 16M | 6M |
| Q4 2024 | 161 | 115M | 60.6% | 26 / 42 | 51 / 35 | 8M | 15M |
| Q3 2024 | 173 | 122M | 64.3% | 22 / 66 | 39 / 38 | 21M | 20M |
| Q2 2024 | 190 | 130M | 68.3% | 45 / 67 | 39 / 15 | 19M | 9M |
| Q1 2024 | 161 | 120M | 63.1% | 28 / 46 | 46 / 18 | 14M | 7M |
| Q4 2023 | 151 | 113M | 59.5% | 30 / 45 | 39 / 18 | 21M | 26M |
| Q3 2023 | 141 | 118M | 62.4% | 14 / 38 | 42 / 19 | 25M | 6M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
100 funds held HRTX in Q2 2026, 72% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of HRTX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 5,474,947 | 2.88% | $2.34M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 3,684,597 | 1.94% | $1.57M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 2,063,361 | 1.09% | $880.64K | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,626,169 | 0.86% | $806.91K | 0.00% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 1,361,330 | 0.72% | $581.02K | 0.00% | Jun 30, 2026 |
| Schwab U.S. Small-Cap ETF | 869,904 | 0.46% | $756.90K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 783,992 | 0.41% | $682.15K | 0.00% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 666,160 | 0.35% | $579.63K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 537,335 | 0.28% | $229.33K | 0.02% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 510,428 | 0.27% | $217.85K | 0.00% | Jun 30, 2026 |
| Vanguard Health Care Index Fund | 415,508 | 0.22% | $361.53K | 0.00% | May 31, 2026 |
| Schwab Small-Cap Index Fund | 413,595 | 0.22% | $205.23K | 0.00% | Jul 31, 2026 |
| Jacob Small Cap Growth Fund | 357,097 | 0.19% | $310.71K | 3.75% | May 31, 2026 |
| Fidelity Total Market Index Fund | 318,641 | 0.17% | $277.25K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 273,188 | 0.14% | $237.70K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Craig A. Collard | Chief Executive Officer, Director | 931,086 | 0.49% | Nov 3, 2026 |
| Mark Earl Hensley | Chief Operating Officer | 201,683 | 0.11% | Nov 10, 2026 |
| William P. Forbes | EVP, Chief Development Officer | 260,734 | 0.14% | Nov 3, 2026 |
| Ira Duarte | EVP, Chief Financial Officer | 302,724 | 0.16% | Nov 3, 2026 |
| Thomas Cusack | Director | 53,960 | 0.03% | Feb 3, 2026 |
| Michael Kaseta | Director | 53,960 | 0.03% | Feb 3, 2026 |
| Craig A. Johnson | Director | 53,960 | 0.03% | Feb 3, 2026 |
| Sharmila Dissanaike | Director | 53,960 | 0.03% | Feb 3, 2026 |
| Adam Morgan | Director | 8,877,027 | 4.68% | Feb 3, 2026 |
| Waage Christian | Director | 53,960 | 0.03% | Feb 3, 2026 |
| Susan Rodriguez | Director | 87,180 | 0.05% | Feb 4, 2025 |
| Capital Management LP Rubric | 10% owner | 26,713,503 | 14.07% | Oct 17, 2025 |
| David Efraim Rosen | 10% owner | 30,046,828 | 15.83% | Oct 17, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Mark Earl Hensley Chief Operating Officer | Nov 6, 2026 | Tax withholding | −8,889 | $0.29 | $2.58K | 201,683 |
| Mark Earl Hensley Chief Operating Officer | Nov 6, 2026 | Option exercise | +31,250 | – | – | 210,572 |
| Craig A. Collard Chief Executive Officer, Director | Oct 31, 2026 | Tax withholding | −8,471 | $0.28 | $2.37K | 931,086 |
| Craig A. Collard Chief Executive Officer, Director | Oct 31, 2026 | Option exercise | +34,788 | – | – | 939,557 |
| Ira Duarte EVP, Chief Financial Officer | Oct 31, 2026 | Tax withholding | −3,327 | $0.28 | $932 | 302,724 |
| Ira Duarte EVP, Chief Financial Officer | Oct 31, 2026 | Option exercise | +11,695 | – | – | 306,051 |
| William P. Forbes EVP, Chief Development Officer | Oct 31, 2026 | Tax withholding | −3,327 | $0.28 | $932 | 260,734 |
| William P. Forbes EVP, Chief Development Officer | Oct 31, 2026 | Option exercise | +11,695 | – | – | 264,061 |
| Craig A. Collard Chief Executive Officer, Director | Oct 30, 2026 | Tax withholding | −12,181 | $0.28 | $3.41K | 904,769 |
| Craig A. Collard Chief Executive Officer, Director | Oct 30, 2026 | Option exercise | +50,021 | – | – | 916,950 |
| Ira Duarte EVP, Chief Financial Officer | Oct 30, 2026 | Tax withholding | −3,850 | $0.28 | $1.08K | 294,356 |
| Ira Duarte EVP, Chief Financial Officer | Oct 30, 2026 | Option exercise | +13,535 | – | – | 298,206 |
| William P. Forbes EVP, Chief Development Officer | Oct 30, 2026 | Tax withholding | −3,349 | $0.28 | $938 | 252,366 |
| William P. Forbes EVP, Chief Development Officer | Oct 30, 2026 | Option exercise | +11,770 | – | – | 255,715 |
| Mark Earl Hensley Chief Operating Officer | Oct 30, 2026 | Tax withholding | −3,349 | $0.28 | $938 | 179,322 |
| Mark Earl Hensley Chief Operating Officer | Oct 30, 2026 | Option exercise | +11,770 | – | – | 182,671 |
| Ira Duarte EVP, Chief Financial Officer | Oct 19, 2026 | Tax withholding | −1,102 | $0.36 | $397 | 284,671 |
| Ira Duarte EVP, Chief Financial Officer | Oct 19, 2026 | Option exercise | +3,874 | – | – | 285,773 |
| William P. Forbes EVP, Chief Development Officer | Oct 19, 2026 | Tax withholding | −1,102 | $0.36 | $397 | 243,945 |
| William P. Forbes EVP, Chief Development Officer | Oct 19, 2026 | Option exercise | +3,874 | – | – | 245,047 |
| Craig A. Collard Chief Executive Officer, Director | Oct 19, 2026 | Tax withholding | −3,360 | $0.36 | $1.21K | 866,929 |
| Craig A. Collard Chief Executive Officer, Director | Oct 19, 2026 | Option exercise | +13,797 | – | – | 870,289 |
| Mark Earl Hensley Chief Operating Officer | Aug 6, 2026 | Tax withholding | −8,888 | $0.50 | $4.44K | 170,901 |
| Mark Earl Hensley Chief Operating Officer | Aug 6, 2026 | Option exercise | +31,250 | – | – | 179,789 |
| Craig A. Collard Chief Executive Officer, Director | Jul 31, 2026 | Option exercise | +34,789 | – | – | 856,492 |
| Ira Duarte EVP, Chief Financial Officer | Jul 31, 2026 | Tax withholding | −3,326 | $0.50 | $1.66K | 281,899 |
| Ira Duarte EVP, Chief Financial Officer | Jul 31, 2026 | Option exercise | +11,694 | – | – | 285,225 |
| Mark Earl Hensley Chief Operating Officer | Jul 31, 2026 | Option exercise | +11,769 | – | – | 148,539 |
| William P. Forbes EVP, Chief Development Officer | Jul 31, 2026 | Tax withholding | −3,326 | $0.50 | $1.66K | 241,173 |
| William P. Forbes EVP, Chief Development Officer | Jul 31, 2026 | Option exercise | +11,694 | – | – | 244,499 |
| Craig A. Collard Chief Executive Officer, Director | Jul 30, 2026 | Option exercise | +50,021 | – | – | 821,703 |
| Ira Duarte EVP, Chief Financial Officer | Jul 30, 2026 | Option exercise | +13,535 | – | – | 277,381 |
| Ira Duarte EVP, Chief Financial Officer | Jul 30, 2026 | Tax withholding | −3,850 | $0.50 | $1.93K | 273,531 |
| William P. Forbes EVP, Chief Development Officer | Jul 30, 2026 | Option exercise | +11,769 | – | – | 236,153 |
| William P. Forbes EVP, Chief Development Officer | Jul 30, 2026 | Tax withholding | −3,348 | $0.50 | $1.67K | 232,805 |
| Ira Duarte EVP, Chief Financial Officer | Jul 19, 2026 | Tax withholding | −1,101 | $0.47 | $517 | 263,846 |
| Ira Duarte EVP, Chief Financial Officer | Jul 19, 2026 | Option exercise | +3,874 | – | – | 264,947 |
| Craig A. Collard Chief Executive Officer, Director | Jul 19, 2026 | Option exercise | +13,797 | – | – | 771,682 |
| William P. Forbes EVP, Chief Development Officer | Jul 19, 2026 | Option exercise | +3,874 | – | – | 225,485 |
| William P. Forbes EVP, Chief Development Officer | Jul 19, 2026 | Tax withholding | −1,101 | $0.47 | $517 | 224,384 |
| Ira Duarte EVP, Chief Financial Officer | Jun 16, 2026 | Option exercise | +12,500 | – | – | 264,628 |
| Ira Duarte EVP, Chief Financial Officer | Jun 16, 2026 | Tax withholding | −3,555 | $0.38 | $1.35K | 261,073 |
| William P. Forbes EVP, Chief Development Officer | Jun 6, 2026 | Option exercise | +12,500 | – | – | 221,611 |
| Mark Earl Hensley Chief Operating Officer | May 6, 2026 | Option exercise | +125,000 | – | – | 136,770 |
| Craig A. Collard Chief Executive Officer, Director | Apr 30, 2026 | Option exercise | +50,021 | – | – | 757,885 |
| Craig A. Collard Chief Executive Officer, Director | Apr 30, 2026 | Option exercise | +34,789 | – | – | 696,841 |
| William P. Forbes EVP, Chief Development Officer | Apr 30, 2026 | Option exercise | +11,694 | – | – | 197,341 |
| William P. Forbes EVP, Chief Development Officer | Apr 30, 2026 | Option exercise | +11,770 | – | – | 209,111 |
| Ira Duarte EVP, Chief Financial Officer | Apr 30, 2026 | Option exercise | +13,535 | – | – | 252,128 |
| Ira Duarte EVP, Chief Financial Officer | Apr 30, 2026 | Option exercise | +11,694 | – | – | 227,570 |
| Mark Earl Hensley Chief Operating Officer | Apr 30, 2026 | Option exercise | +11,770 | – | – | 11,770 |
| William P. Forbes EVP, Chief Development Officer | Apr 19, 2026 | Option exercise | +3,874 | – | – | 185,647 |
| Ira Duarte EVP, Chief Financial Officer | Apr 19, 2026 | Option exercise | +3,874 | – | – | 215,876 |
| Craig A. Collard Chief Executive Officer, Director | Apr 19, 2026 | Option exercise | +13,797 | – | – | 662,052 |
| Craig A. Collard Chief Executive Officer, Director | Apr 3, 2026 | Option exercise | +62,500 | – | – | 648,255 |
| Ira Duarte EVP, Chief Financial Officer | Jan 31, 2026 | Option exercise | +11,695 | – | – | 195,356 |
| William P. Forbes EVP, Chief Development Officer | Jan 31, 2026 | Option exercise | +11,695 | – | – | 181,773 |
| Craig A. Collard Chief Executive Officer, Director | Jan 31, 2026 | Option exercise | +34,789 | – | – | 571,710 |
| Michael Kaseta Director | Jan 30, 2026 | Award | +53,960 | – | – | 53,960 |
| Sharmila Dissanaike Director | Jan 30, 2026 | Award | +53,960 | – | – | 53,960 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Heron Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 210,633 shares on Sep 30, 2026 over the last 90 days.
Congress trades
1 trade in Heron Therapeutics reported by 1 member of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Ashley Hinson Arenholz IA01 · spouse | Sold | Mar 31, 2021 | $1K–15K | Apr 5, 2021 |
See a number that looks wrong?